## MKSI: MKS Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.61 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($154.66)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. MKS Instruments stock hits 52-week high at 167.38 USD**
- Source: Investing.com | 20251210T145320 | Bullish | Relevance: 98%
-  MKS Instruments (MKSI) stock reached a new 52-week high of $167.38, reflecting significant upward growth with a 50.19% return over the past year and 76.09% in six months. Despite being considered overvalued by InvestingPro, analysts remain bullish with price targets up to $200, driven by strong Q3 2025 earnings and positive outlook for its semiconductor business. The company has also maintained dividend payments for 15 consecutive years, further attracting investor attention.

**2. Frontier Capital Management Co. LLC Boosts Stock Position in MKS Inc. $MKSI**
- Source: MarketBeat | 20251211T100952 | Somewhat-Bullish | Relevance: 98%
- Frontier Capital Management Co. LLC significantly increased its stake in MKS Inc. (NASDAQ:MKSI) by 146.4% in the second quarter, acquiring an additional 542,094 shares. MKS now accounts for 0.8% of Frontier Capital's holdings, making it their 17th largest position. Other institutional investors also adjusted their positions in MKSI, and the company has received a "Moderate Buy" consensus rating from analysts with an average target price of $159.64.

**3. Federated Hermes Inc. Purchases 31,815 Shares of MKS Inc. $MKSI**
- Source: MarketBeat | 20251211T090952 | Bullish | Relevance: 98%
-  Federated Hermes Inc. increased its stake in MKS Inc. by 38.0% during the second quarter, acquiring an additional 31,815 shares and now owning 0.17% of the company valued at $11.485 million. Other institutional investors also adjusted their holdings in MKS. The company recently declared a quarterly dividend of $0.22 and its stock is trading at $167.88, with a market cap of $11.28 billion.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Citigroup | $185 | $122 | +52% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 7 ($1.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+4.0%)
- Blackrock Inc.: 9.1% (-16.3%)
- Price (T.Rowe) Assoc: 5.4% (-12.0%)
- Victory Capital Mana: 5.3% (-7.3%)
- FMR, LLC: 5.1% (-10.1%)

### Key Risks

1. High beta (1.93) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +1.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.61 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.9x). Analyst sentiment positive (1 raises, avg +52%). Insider selling cluster ($1.3M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $11.2B |
| Beta | 1.93 |
| 52W Range | $54.84 - $170.37 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.61 |
| Forward P/E | 19.1 |
| Current P/E | 21.6 |
| YoY Growth | 13.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 5.2% to 6.4% (+1.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 82nd percentile. MRS_5 at 0.8% confirms short-term momentum alignment. AM_20 at 8.6% shows strong absolute momentum above own 20MA. Outperforming sector by 5.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.99), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.36% (CS: 83) | Strong |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 0.99 | Bullish |
| vs SMA20 | 1.085x | Above |
| vs SMA50 | 1.144x | Above |
| vs SMA200 | 1.569x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $166.80
- **Stop Loss:** $154.66 (7.3% risk)
- **Target:** $191.08 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 113
- **Position Value:** $18,848.40
- **Portfolio %:** 18.85%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-11 (Est: $2.30)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.85 | $1.93 | +4.1% |
| 2025Q2 | $1.64 | $1.77 | +8.1% |
| 2025Q1 | $1.45 | $1.71 | +17.5% |
| 2024Q4 | $1.96 | $2.15 | +10.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*